trial · primary record
Guselkumab
Arthritis, Psoriatic
| Phase | Phase 3 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 453 |
| Primary completion | 2026-07-02 |
| Primary endpoint | Percentage of Participants Who Achieved an American College of Rheumatology (ACR) 20 Response at Week 24 |
| Registry ID | NCT04936308 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:40.747Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04936308
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Guselkumab · approval
- Guselkumab · compound